Makoto Nakamuta

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease

Motoyuki Kohjima, Munechika Enjoji, Nobito Higuchi et al. · International Journal of Molecular Medicine · 2007 · 525 citations · Full text

Pathology, Fatty Liver Disease, Metabolic Syndrome +18

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease

Motoyuki Kohjima, Nobito Higuchi, Masaki Kato et al. · International Journal of Molecular Medicine · 2008 · 362 citations · Full text

Fatty Liver Disease, Insulin Signaling, Obesity +21

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima et al. · Journal of Gastroenterology · 2015 · 326 citations · Full text

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +10

Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

Nobito Higuchi, Masaki Kato, Yuki Shundo et al. · Hepatology Research · 2008 · 280 citations